APA (7th ed.) Citation

Cutler, C., Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., . . . Antin, J. H. (2014). Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood, 124(8), 1372-1377. https://doi.org/10.1182/blood-2014-04-567164

Chicago Style (17th ed.) Citation

Cutler, Corey, et al. "Tacrolimus/sirolimus Vs Tacrolimus/methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT." Blood 124, no. 8 (2014): 1372-1377. https://doi.org/10.1182/blood-2014-04-567164.

MLA (9th ed.) Citation

Cutler, Corey, et al. "Tacrolimus/sirolimus Vs Tacrolimus/methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT." Blood, vol. 124, no. 8, 2014, pp. 1372-1377, https://doi.org/10.1182/blood-2014-04-567164.